Journal article

Stabilization of nontoxic Ajβ-oligomers: Insights into the mechanism of action of hydroxyquinolines in alzheimer’s disease

TM Ryan, BR Roberts, G McColl, DJ Hare, PA Doble, QX Li, M Lind, AM Roberts, HDT Mertens, N Kirb, CLL Pham, MG Hinds, PA Adlard, KJ Barnham, CC Curtain, CL Masters

Journal of Neuroscience | SOC NEUROSCIENCE | Published : 2015

Abstract

The extracellular accumulation of amyloid β (A/β) peptides is characteristic of Alzheimer's disease (AD). However, formation of diffusible, oligomeric forms of Aβ, both on and off pathways to amyloid fibrils, is thought to include neurotoxic species responsible for synaptic loss and neurodegeneration, rather than polymeric amyloid aggregates. The 8-hydroxyquinolines (8-HQ) clioquinol (CQ) and PBT2 were developed for their ability to inhibit metal-mediated generation of reactive oxygen species from A/β:Cu complexes and have both undergone preclinical and Phase II clinical development for the treatment of AD. Their respective modes of action are not fully understood and may include both inhibi..

View full abstract

Grants

Awarded by Australian National Health and Medical Research Council


Funding Acknowledgements

The work was supported by the Australian National Health and Medical Research Council Program Grant 628946 and Project Grant 1050751 (G.M.), the Knott Family Equipment Grant, and the Pierce Armstrong Trust Grant. T.M.R. was supported by the Australian Alzheimer's Dementia Research Foundation full fellowship. The Florey Institute of Neuroscience and Mental Health is supported by Operational Infrastructure Support funding from the Victorian State Government. The authors thank Dr. Robert Cherny and Prana Biotechnology for their comments on our data.